Biodesix Inc. (BDSX) Tops Q3 EPS by 1c

Biodesix Inc. (NASDAQ: BDSX) reported Q3 EPS of ($0.14), $0.01 better than the analyst estimate of ($0.15). Revenue for the quarter came in at $13.5 million versus the consensus estimate of $14.38 million.

For earnings history and earnings-related data on Biodesix Inc. (BDSX) click here.

You May Also Be Interested In

• Ackman adds Netflix, Visa and Mastercard in portfolio revamp
• Lucid Diagnostics Inc. (LUCD) Reports In-Line Q2 EPS
• SPAR Group (SGRP) Reports Q2 EPS of $0.04